Exome Asset Management LLC Portfolio Holdings

Exome Asset Management LLC

  • $112 Billion
  • Q1 2025

Exome Asset Management LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $112 Billion distributed in 59 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $5.72B, Guardant Health, Inc. with a value of $5.42B, Geron Corp with a value of $5.11B, Astrazeneca PLC with a value of $4.73B, and Cytokinetics Inc with a value of $4.16B.

Examining the 13F form we can see an decrease of $20.6B in the current position value, from $133B to 112B.

Exome Asset Management LLC is based out at New York, NY

Below you can find more details about Exome Asset Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $112 Billion
Healthcare: $93.7 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.68B
$5.72 Billion 5.09% of portfolio
165,496
Q1 2025 Reduced 32.92%
$5.06B
$5.42 Billion 4.82% of portfolio
127,182
Q1 2025 Reduced 13.95%
$589M
$5.11 Billion 4.54% of portfolio
3,215,457
Q1 2025 Added 105.97%
$229B
$4.73 Billion 4.2% of portfolio
32,534
Q1 2025 New
$3.12B
$4.16 Billion 3.7% of portfolio
103,483
Q1 2025 Added 57.07%
$631M
$4.14 Billion 3.68% of portfolio
337,198
Q1 2025 Added 5.74%
$5.22B
$4.09 Billion 3.64% of portfolio
135,616
Q1 2025 Added 120.99%
$767B
$3.86 Billion 3.43% of portfolio
4,673
Q1 2025 Reduced 43.34%
$402M
$3.72 Billion 3.31% of portfolio
621,678
Q1 2025 New
$187B
$3.15 Billion 2.8% of portfolio
6,358
Q1 2025 Reduced 14.39%
Soleno Therapeutics Inc
-
$3.1 Billion 2.76% of portfolio
-
Q1 2025 Reduced 43.79%
$2.54B
$3.09 Billion 2.75% of portfolio
76,379
Q1 2025 Added 11.33%
Disc Medicine Inc
-
$3.06 Billion 2.72% of portfolio
-
Q1 2025 Reduced 10.74%
$579M
$2.93 Billion 2.6% of portfolio
217,294
Q1 2025 New
$361M
$2.9 Billion 2.58% of portfolio
405,281
Q1 2025 New
$481M
$2.87 Billion 2.56% of portfolio
294,846
Q1 2025 Added 438.65%
$737M
$2.7 Billion 2.4% of portfolio
258,391
Q1 2025 New
$15.9B
$2.64 Billion 2.34% of portfolio
18,650
Q1 2025 Reduced 16.93%
$473M
$2.57 Billion 2.29% of portfolio
353,882
Q1 2025 Added 57.06%
$9.69B
$2.41 Billion 2.14% of portfolio
9,000
Q4 2024 New
$285M
$2.32 Billion 2.06% of portfolio
836,397
Q1 2025 Added 19.54%
Anaptysbio Inc
-
$2.17 Billion 1.93% of portfolio
-
Q1 2025 New
$957M
$2.11 Billion 1.88% of portfolio
118,017
Q1 2025 New
$1.12B
$2.05 Billion 1.82% of portfolio
142,744
Q1 2025 Added 3.65%
Ge Healthcare Technologies I
-
$2.05 Billion 1.82% of portfolio
-
Q1 2025 New
$376M
$1.98 Billion 1.76% of portfolio
689,137
Q1 2025 Added 143.0%
Structure Therapeutics Inc
-
$1.78 Billion 1.58% of portfolio
-
Q1 2025 Reduced 32.26%
$112M
$1.78 Billion 1.58% of portfolio
263,841
Q1 2025 New
$23.5B
$1.77 Billion 1.57% of portfolio
6,500
Q1 2025 Reduced 35.0%
$1.78B
$1.72 Billion 1.53% of portfolio
51,295
Q1 2025 New
$936M
$1.57 Billion 1.4% of portfolio
71,438
Q1 2025 Reduced 12.32%
$2.64B
$1.55 Billion 1.38% of portfolio
117,500
Q4 2024 Added 223.69%
Corbus Pharmaceuticals Hldgs
-
$1.54 Billion 1.37% of portfolio
-
Q1 2025 New
$126M
$1.52 Billion 1.35% of portfolio
2,232,453
Q1 2025 Added 261.14%
Karyopharm Therapeutics Inc
-
$1.52 Billion 1.35% of portfolio
-
Q1 2025 New
$417M
$1.37 Billion 1.22% of portfolio
195,295
Q1 2025 Reduced 10.7%
$118M
$1.21 Billion 1.07% of portfolio
1,097,999
Q4 2024 Added 134.37%
$353M
$1.03 Billion 0.92% of portfolio
163,738
Q1 2025 New
Mbx Biosciences Inc
-
$982 Million 0.87% of portfolio
-
Q1 2025 New
Biohaven LTD
-
$959 Million 0.85% of portfolio
-
Q1 2025 Added 41.7%
$2.85B
$871 Million 0.77% of portfolio
90,100
Q3 2024 New
Vyne Therapeutics Inc
-
$731 Million 0.65% of portfolio
-
Q1 2025 Added 30.94%
$923M
$535 Million 0.48% of portfolio
13,100
Q4 2024 Reduced 39.63%
$2.07B
$455 Million 0.4% of portfolio
60,600
Q1 2025 New
$43.6M
$387 Million 0.34% of portfolio
114,145
Q1 2025 Reduced 55.48%
$632M
$363 Million 0.32% of portfolio
189,087
Q1 2025 Reduced 8.19%
$539M
$170 Million 0.15% of portfolio
96,311
Q1 2025 New
Aprea Therapeutics Inc
-
$59.1 Million 0.05% of portfolio
-
Q1 2025 Reduced 77.36%

Summary

  • Portfolio
  • No. of Stocks 59
  • Current Value $112 Billion
  • Prior Value $133 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 16 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email